Document Detail


Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women.
MedLine Citation:
PMID:  12817182     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Asymmetric dimethylarginine (ADMA) is an endogenous inhibitor of nitric oxide (NO), which plays an important role in natriuresis. We determined whether changes in endothelium-dependent vasodilation (EDD) and plasma ADMA predict changes in blood pressure (BP) after salt loading in normotensive postmenopausal women (PMW). METHODS: In 15 normotensive PMW (age 50-60 years), not receiving estrogen, ambulatory 24-h BP, plasma lipids, and ADMA were measured after 4 days of a low-salt diet (70 mEq/day) and following 7 days of high-salt intake (260 mEq/day). Brachial artery diameter at rest, during reactive hyperemia, i.e. EDD, and after sublingual nitroglycerin, i.e. non-EDD, were measured by ultrasound. The 24-h urinary NO metabolite (NOx) was measured by Griess reaction. Plasma ADMA was measured by high-pressure liquid chromatography. RESULTS: During low-salt, 24-h BP levels averaged 121 +/- 11 and 69 +/- 7 mmHg for systolic BP (SBP) and diastolic BP (DBP), respectively. After salt loading, average 24-h BP increases were: 7.6 mmHg for SBP, 2.2 mmHg for DBP, and 5.5 mmHg for pulse pressure (PP). Increases of 24-h SBP and 24-h PP after salt loading correlated directly with changes in ADMA (partial R2 = 0.16 for 24-h SBP and 0.17 for 24-h PP, P < 0.05 for both) and inversely with changes in EDD (partial R2 = 0.13, P = 0.09 for 24 h SBP and partial R2 = 0.15, P = 0.07 for 24-h PP), after adjustment for age and cholesterol. CONCLUSIONS: Inhibition of NO bioavailability by ADMA and a subsequent reduction in EDD contribute to the increase in BP during high-salt intake in normotensive PMW not receiving estrogen.
Authors:
Angelo Scuteri; Markus C Stuehlinger; John P Cooke; Jeanette G Wright; Edward G Lakatta; David E Anderson; Jerome L Fleg
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Journal of hypertension     Volume:  21     ISSN:  0263-6352     ISO Abbreviation:  J. Hypertens.     Publication Date:  2003 Jul 
Date Detail:
Created Date:  2003-06-20     Completed Date:  2004-04-06     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8306882     Medline TA:  J Hypertens     Country:  England    
Other Details:
Languages:  eng     Pagination:  1339-46     Citation Subset:  IM    
Affiliation:
Laboratory of Cardiovascular Science, National Institute on Aging, NIH, Baltimore, Maryland, USA. angeloelefante@interfree.it
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Arginine / analogs & derivatives*,  blood*
Blood Pressure / drug effects,  physiology*
Brachial Artery / physiology
Endothelium, Vascular / metabolism
Female
Humans
Middle Aged
Natriuresis / drug effects,  physiology
Nitric Oxide / blood*
Postmenopause / metabolism*
Predictive Value of Tests
Regression Analysis
Sodium Chloride, Dietary / administration & dosage*
Vasodilation / physiology
Grant Support
ID/Acronym/Agency:
R01 HL-58638/HL/NHLBI NIH HHS; R01 HL-63685/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Sodium Chloride, Dietary; 10102-43-9/Nitric Oxide; 30315-93-6/N,N-dimethylarginine; 74-79-3/Arginine
Comments/Corrections
Comment In:
J Hypertens. 2003 Jul;21(7):1255-7   [PMID:  12817168 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Haplotype analysis of aldosterone synthase gene (CYP11B2) polymorphisms shows association with essen...
Next Document:  Perindopril augments ecto-ATP diphosphohydrolase activity and enhances endothelial anti-platelet fun...